Cosmowell Biotech And Nutrition (Opc) Private Limited
Founded in 2018 and headquartered in Telangana, India.
2018 | Hyderabad, Telangana (India) | Active
Cosmowell Biotech And Nutrition (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 607.30%
- Profit Growth -87.42%
- Ebitda -87.42%
- Net Worth -32.72%
- Total Assets 15.17%
About Cosmowell Biotech And Nutrition (Opc)
Cosmowell Biotech And Nutrition (Opc) Private Limited (CBANOPL) is a Company incorporated in India on 06 December 2018 (Six years and two months 24 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shveta Patil serves as a director at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01100TG2018OPC128807
- Company No.
128807
- Incorporation Date
06 Dec 2018
- Date of AGM
13 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Agriculture
Who are the key members and board of directors at Cosmowell Biotech And Nutrition (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shveta Patil  | Director | 06-Dec-2018 | Current |
Financial Performance of Cosmowell Biotech And Nutrition (Opc).
Cosmowell Biotech And Nutrition (Opc) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 607.3% increase. The company also saw a substantial fall in profitability, with a 87.42% decrease in profit. The company's net worth observed a substantial decline by a decrease of 32.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cosmowell Biotech And Nutrition (Opc)?
Unlock access to Cosmowell Biotech And Nutrition (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cosmowell Biotech And Nutrition (Opc)?
Unlock and access historical data on people associated with Cosmowell Biotech And Nutrition (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cosmowell Biotech And Nutrition (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosmowell Biotech And Nutrition (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.